Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects with B-Cell Chronic Lymphocytic Leukemia Relapsed or Refractory to Purine Nucleoside Treatment

Sponsor ID

20040240

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

AMG 623

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.